RetractedArticleCell cycle (Georgetown, Tex.)2022

Hsa-miR-186-3p suppresses colon cancer progression by inhibiting KRT18/MAPK signaling pathway.

Tian Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.